You are currently viewing Pakistan to start manufacturing anti-Covid-19 drug: SAPM Zafar Mirza

Pakistan to start manufacturing anti-Covid-19 drug: SAPM Zafar Mirza

  • Post author:
  • Post category:Featured / Health
  • Post last modified:15/05/2020
  • Reading time:1 mins read

ISLAMABAD: Pakistan will soon start manufacturing anti-viral drug remdesivir to fight novel coronavirus under the license from a United States pharmaceutical company, said Special Assistant to the Prime Minister on National Health Services Dr Zafar Mirza.

Addressing a news briefing at the National Command and Operation Centre (NCOC) here today, the SAPM said that a national pharmaceutical company has reached an agreement with US-based Gilead for a voluntary license for the manufacture and sale of the anti-Covid-19 drug in Pakistan.

“The US-based company has allowed five countries to produce remdesivir to treat coronavirus patients. Pakistan is also among those to receive the license of the company,” he said, adding that the country will start production of the medicine as early as eight weeks after the necessary regulatory approvals are obtained.

The PM’s special aide further added that Pakistan will also be able to export the medicine to 127 countries.

M M Alam

M. M. Alam is a Pakistan-based working journalist since 1981. Karachi University faculty gold medalist Alam began his career four decades ago by writing for Dawn, Pakistan’s highest circulating English daily. He has worked for region’s leading publications, global aviation periodicals including Rotors (of USA) and vetted New York Times as permanent employee of daily Express Tribune. Alam regularly covers international aviation and defense-related events including Salon Du Bourget (France), Farnborough (United Kingdom), Dubai (UAE). Alam has reported thousands of events and interviewed hundreds of people in Pakistan, UAE, EU, UK and USA. Being Francophone Alam also coordinates with a number of French publications.